Roche, Toyama Chemical enter licensing pact for arthritis drug
Tuesday, June 26, 2007 10:00 IST Basel
Toyama Chemical Co., Ltd. and Roche announced that they have entered into a licensing agreement for the worldwide research, development and commercialization of Toyama Chemical's novel oral rheumatoid arthritis agent T-5224.